| |  Online-Ressource |
|---|
| Verfasst von: | Giesen, Nicola [VerfasserIn]  |
|---|
| | Sprute, Rosanne [VerfasserIn] |
|---|
| | Rüthrich, Maria Madeleine [VerfasserIn] |
|---|
| | Khodamoradi, Yascha [VerfasserIn] |
|---|
| | Mellinghoff, Sibylle Christiane [VerfasserIn] |
|---|
| | Beutel, Gernot [VerfasserIn] |
|---|
| | Lück, Catherina [VerfasserIn] |
|---|
| | Koldehoff, Michael [VerfasserIn] |
|---|
| | Hentrich, Marcus [VerfasserIn] |
|---|
| | Sandherr, Michael [VerfasserIn] |
|---|
| | Bergwelt, Michael von [VerfasserIn] |
|---|
| | Wolf, Hans-Heinrich [VerfasserIn] |
|---|
| | Hirsch, Hans H. [VerfasserIn] |
|---|
| | Wörmann, Bernhard [VerfasserIn] |
|---|
| | Cornely, Oliver Andreas [VerfasserIn] |
|---|
| | Köhler, Philipp [VerfasserIn] |
|---|
| | Schalk, Enrico [VerfasserIn] |
|---|
| | Lilienfeld-Toal, Marie von [VerfasserIn] |
|---|
| Titel: | Evidence-based management of COVID-19 in cancer patients |
|---|
| Titelzusatz: | guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) |
|---|
| Verf.angabe: | Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr, Michael von Bergwelt-Baildon, Hans-Heinrich Wolf, Hans H. Hirsch, Bernhard Wörmann, Oliver A. Cornely, Philipp Köhler, Enrico Schalk, Marie von Lilienfeld-Toal |
|---|
| E-Jahr: | 2020 |
|---|
| Jahr: | 21 September 2020 |
|---|
| Umfang: | 19 S. |
|---|
| Fussnoten: | Gesehen am 21.01.2020 |
|---|
| Titel Quelle: | Enthalten in: European journal of cancer |
|---|
| Ort Quelle: | Amsterdam [u.a.] : Elsevier, 1965 |
|---|
| Jahr Quelle: | 2020 |
|---|
| Band/Heft Quelle: | 140(2020), Seite 86-104 |
|---|
| ISSN Quelle: | 1879-0852 |
|---|
| Abstract: | Since its first detection in China in late 2019 the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious disease COVID-19 continue to have a major impact on global healthcare and clinical practice. Cancer patients, in particular those with haematological malignancies, seem to be at an increased risk for a severe course of infection. Deliberations to avoid or defer potentially immunosuppressive therapies in these patients need to be balanced against the overarching goal of providing optimal antineoplastic treatment. This poses a unique challenge to treating physicians. This guideline provides evidence-based recommendations regarding prevention, diagnostics and treatment of SARS-CoV-2 infection and COVID-19 as well as strategies towards safe antineoplastic care during the COVID-19 pandemic. It was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) by critically reviewing the currently available data on SARS-CoV-2 and COVID-19 in cancer patients applying evidence-based medicine criteria. |
|---|
| DOI: | doi:10.1016/j.ejca.2020.09.009 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1016/j.ejca.2020.09.009 |
|---|
| | Volltext: http://www.sciencedirect.com/science/article/pii/S0959804920304937 |
|---|
| | DOI: https://doi.org/10.1016/j.ejca.2020.09.009 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Cancer |
|---|
| | Coronavirus |
|---|
| | COVID-19 |
|---|
| | Guideline |
|---|
| | Haematological malignancy |
|---|
| | SARS-CoV-2 |
|---|
| K10plus-PPN: | 1738733262 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Evidence-based management of COVID-19 in cancer patients / Giesen, Nicola [VerfasserIn]; 21 September 2020 (Online-Ressource)
